Clinical trials
Recruiting Recurrence trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
540 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2013 | 2 |
| 2014 | 6 |
| 2015 | 3 |
| 2016 | 6 |
| 2017 | 3 |
| 2018 | 11 |
| 2019 | 11 |
| 2020 | 15 |
| 2021 | 28 |
| 2022 | 39 |
| 2023 | 73 |
| 2024 | 113 |
| 2025 | 138 |
| 2026 | 87 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 540 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 13 |
| Sun Yat-sen University | 9 |
| The First Affiliated Hospital of Soochow University | 9 |
| Beijing Biotech | 8 |
| Fudan University | 7 |
| Institute of Hematology & Blood Diseases Hospital, China | 7 |
| Regeneron Pharmaceuticals | 7 |
| UNC Lineberger Comprehensive Cancer Center | 6 |
| AstraZeneca | 5 |
| Chinese PLA General Hospital | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 540 |
| Multiple Myeloma | 52 |
| Neoplasms | 45 |
| Neoplasm Metastasis | 42 |
| Leukemia, Myeloid, Acute | 37 |
| Lymphoma | 29 |
| Lymphoma, Non-Hodgkin | 24 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 23 |
| Lymphoma, Large B-Cell, Diffuse | 20 |
| Lymphoma, B-Cell | 19 |
Trials
Showing 76 to 100 of 540. Each trial links to its page on Pharma Observatory.
440 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.